Tumor organoids: From inception to future in cancer research.

Tumor organoids: From inception to future in cancer research.

Publication date: Apr 11, 2019

Tumor models have created new avenues for personalized medicine and drug development. A new culture model derived from a three-dimensional system, the tumor organoid, is gradually being used in many fields. An organoid can simulate the physiological structure and function of tissue in situ and maintain the characteristics of tumor cells in vivo, overcoming the disadvantages of traditional experimental tumor models. Organoids can mimic pathological features of tumors and maintain genetic stability, making them suitable for both molecular mechanism studies and pharmacological experiments of clinical transformation. In addition, the application of tumor organoids combined with other technologies, such as liquid biopsy technology, microraft array (MRA), and high-content screening (HCS), for the development of personalized diagnosis and cancer treatment has a promising future. In this review, we introduce the evolution of organoids and discuss their specific application and advantages. We also summarize the characteristics of several tumor organoids culture systems.

Yang, L., Yang, S., Li, X., Li, B., Li, Y., Zhang, X., Ma, Y., Peng, X., Jin, H., Fan, Q., Wei, S., Liu, J., and Li, H. Tumor organoids: From inception to future in cancer research. 04416. 2019 Cancer Lett.

Concepts Keywords
Drug Development Drug development
Evolution Tissue engineering
Genetic Organoid
Pharmacological Stem cells
Tumor Traditional experimental tumor
Vivo Characteristics tumor
Pathological tumors
Dimensional system tumor


Type Source Name
disease MESH diagnosis
disease MESH development
disease DOID cancer
disease MESH Tumor


Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *